Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Equilis Prequenza Te   
Auth. number : EU/2/05/057
INN : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI05 - Immunologicals for equidae
Pharmacological subgroup: QI05A - Horse
Chemical subgroup: QI05AL - Inactivated viral and inactivated bacterial vaccines
Chemical substance: QI05AL01 - Equine influenza virus + Clostridium
(See WHO ATCvet Index)
Indication: Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality.
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/07/2005 Centralised - Authorisation EMEA/V/C/95 (2005)2727 of 08/07/2005
12/01/2006 Centralised - Variation EMEA/V/C/95/IB/1
Updated with Decision(2006)3716 of 10/08/2006
14/08/2006 Centralised - Variation (2006)3716 of 10/08/2006
19/03/2007 Centralised - Variation EMEA/V/C/95/II/2
21/05/2008 Centralised - Variation EMEA/V/C/95/II/4
15/07/2008 Centralised - Variation EMEA/V/C/95/X/3 (2008)3713 of 11/07/2008
25/03/2009 Centralised - Variation EMEA/V/C/95/II/5 (2009)2201 of 23/03/2009
11/05/2010 Centralised - Variation EMEA/V/C/95/IG/1
29/07/2010 Centralised - Renewal EMEA/V/C/95/R/6 (2010)5323 of 27/07/2010
12/04/2013 Centralised - Variation EMEA/V/C/95/X/8/G (2013)2134 of 10/04/2013